Serum concentrations of 1,25-dihydroxycholecalciferol and 25-hydroxycholecalciferol in clinically normal dogs and dogs with acute and chronic renal failure

American Journal of Veterinary Research

Volumn 64, Issue 9, 2003, Pages 1161-1166

  Gerber, Bernhard ^a   Hässig, Michael ^a   Reusch, Claudia E ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIFEDIOL; CALCITRIOL; PARATHYROID HORMONE;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ARTICLE; CHRONIC KIDNEY FAILURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOG; DRUG BLOOD LEVEL; FEMALE; MALE; NONHUMAN; PARATHYROID HORMONE BLOOD LEVEL; PROTEIN BINDING; RADIOIMMUNOASSAY; REFERENCE VALUE; URINARY EXCRETION; VITAMIN METABOLISM;

ANIMALS; CALCIFEDIOL; CALCITRIOL; CALCIUM; CREATININE; DOG DISEASES; DOGS; FEMALE; KIDNEY FAILURE, ACUTE; KIDNEY FAILURE, CHRONIC; MALE; PARATHYROID HORMONE; PHOSPHORUS; UREA;

ANIMALIA; CANIS FAMILIARIS;

EID: 0042383212     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2003.64.1161     Document Type: Article

References (28)

1. Llach F, Bover J. Renal osteodystrophies. In: Brenner BM, ed. Brenner & Rector's the kidney. Philadelphia: WB Saunders Co, 2000;2103-2186.
2. Ganong WF. Hormonal control of calcium metabolism and the physiology of bone. In: Ganong WF, ed. Review of medical physiology. New York: Lange Medical Books/McGraw-Hill Book Co, 2001;369-382.
3. Mawer EB, Taylor CM, Backhouse J, et al. Failure of formation of 1,25-dihydroxycholecalciferol in chronic renal insufficiency. Lancet 1973;1:626-628.
4. Rosol TJ, Chew DJ, Nagode LA, et al. Disorders of calcium. In: DiBartola SP, ed. Fluid therapy in small animal practice. Philadelphia: WB Saunders Co, 2000;108-162.
5. 2D receptors are decreased in parathyroid glands from chronically uremic dogs. Kidney Int 1989;35:19-23.
6. Lopez-Hilker S, Dusso AS, Rapp NS, et al. Phosphorus restriction reverses hyperparathyroidism in uremia independent of changes in calcium and calcitriol. Am J Physiol 1990;259:F432-F437.
7. Dzanis DA, Corbellini CN, Krook L, et al. Effects of 1,25-dihydroxycholecalciferol and 24,25-dihydroxycholecalciferol in dogs with impaired renal function. J Nutr 1991;121:S70-S72.
8. Saba H, Mustonen J, Pietila, K, et al. Metabolism of calcium and vitamin D3 in patients with acute tubulointerstitial nephritis: a study of 41 patients with nephropathia epidemica. Nephron 1993;63:159-163.
9. Brady HR, Brenner BM, Clarkson MR, et al. Acute renal failure. In: Brenner BM, ed. Brenner & Rector's the kidney. Philadelphia: WB Saunders Co, 2000;1201-1262.
10. Kawaguchi Y, Kimura Y, Yamamoto M, et al. Graded nephron mass reduction and renal synthesis of 1,25-dihydroxyvitamin D3 in the rat. Metab Bone Dis Relat Res 1983;4:333-336.
11. Rucker RB, Morris JG. The vitamins. In: Kaneko JJ, Harvey JW , Bruss ML, eds. Clinical biochemistry of domestic animals. San Diego: Academic Press Inc, 1997;703-739.
12. Hsu CH, Patel S, Young EW, et al. Production and metabolic clearance of calcitriol in acute renal failure. Kidney Int 1988;33:530-535.
13. Cunningham J, Bikle DD, Avioli LV. Acute, but not chronic, metabolic acidosis disturbs 25-hydroxivitamin D3 metabolism. Kidney Int 1984;25:47-52.
14. Krapf R, Vetsch R, Vetsch W, et al. Chronic metabolic acidosis increases the serum concentration of 1,25-dihydroxyvitamin D in humans by stimulating its production rate. J Clin Invest 1992;90: 2456-2463.
15. Offermann G, Herrath D, Schaefer K. Serum 25-hydroxycholecalciferol in uremia. Nephron 1974;13:269-277.
16. Barragry JM, France MW, Carter ND, et al. Vitamin-D metabolism in nephrotic syndrome. Lancet 1977;2:629-632.
17. Schmidt-Gayk H, Grawunder C, Tschop W et al. 25-hydroxy-vitamin-D in nephrotic syndrome. Lancet 1977;2:105-108.
18. Belsey RE, DeLuca HF, Potts JT. A rapid assay for 25-OH-vitamin D3 without preparative chromatography. J Clin Endocrinol Metab 1974;38:1046-1051.
19. Martinez I, Saracho R, Montenegro J, et al. A deficit of calcitriol synthesis may not be the initial factor in the pathogenesis of secondary hyperparathyroidism. Nephrol Dial Transplant 1996; 11:22-28.
20. Hsu CH, Patel SR, Young EW. Mechanism of decreased calcitriol degradation in renal failure. Am J Physiol 1992;262:F192-F198.
21. Dusso A, Lopez-Hilker S, Lewis-Finch J, et al. Metabolic clearance rate and production rate of calcitriol in uremia. Kidney Int 1989;35:860-864.
22. Rosol TJ, Capen CC. Pathophysiology of calcium, phosphorus, and magnesium metabolism in animals. Vet Clin North Am Small Anim Pract 1996;26:1155-1184.
23. Meller Y, Kestenbaum RS, Yagil R, et al. The influence of age and sex and blood levels of calcium-regulating hormones in dogs. Clin Orthop 1984;187:296-299.
24. Rosol TJ, Nagode LA, Couto CG, et al. Parathyroid hormone (PTH)-related protein, PTH, and 1,25-dihydroxyvitamin D in dogs with cancer-associated hypercalcemia. Endocrinology 1992;131:1157-1164.
25. 2D3 on PTH levels and bone histology in dogs with chronic uremia. Kidney Int 1984;26:791-797.
26. Aguilera-Tejero E, López I, Estepa C, et al. Mineral metabolism in healthy geriatric dogs. Res Vet Sci 1998;64:191-194.
27. Chew DJ, Nagode LA, Carothers M. Disorders of calcium: hypercalcemia and hypocalcemia. In: DiBartola SP ed. Fluid therapy in small animal practice. Philadelphia: WB Saunders Co, 1992; 116-176.
28. Sato KA, Gray RW, Lemann J. Urinary excretion of 25-hydroxyvitamin D in health and the nephrotic syndrome. J Lab Clin Med 1982;99:325-330.